Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
| Buy | Overweight | Hold | Underweight | Sell |
|---|---|---|---|---|
| 4 | 0 | 4 | 1 | 1 |
Analyst Firms Making Recommendations1
- Credit Suisse
- Cantor Fitzgerald
- Roth Capital
- HC Wainwright & Co.
- Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Humanigen
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/03/2023 | HGEN | Buy Now | Humanigen | $0.01 | 4445.45% | Credit Suisse | Tiago Fauth | → $0.5 | Reiterates | → Underperform | Get Alert |
| 01/11/2023 | HGEN | Buy Now | Humanigen | $0.01 | 1263.64% | Cantor Fitzgerald | Louise Chen | → $0.15 | Reinstates | → Neutral | Get Alert |
| 07/13/2022 | HGEN | Buy Now | Humanigen | $0.01 | 18081.82% | Roth Capital | Tony Butler | $13 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 07/13/2022 | HGEN | Buy Now | Humanigen | $0.01 | 18081.82% | Cantor Fitzgerald | Louise Chen | $30 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 07/13/2022 | HGEN | Buy Now | Humanigen | $0.01 | — | HC Wainwright & Co. | Joseph Pantginis | — | Downgrade | Buy → Neutral | Get Alert |
| 09/10/2021 | HGEN | Buy Now | Humanigen | $0.01 | 81718.18% | Jefferies | Kelly Shi | — | Downgrade | Buy → Hold | Get Alert |
| 09/09/2021 | HGEN | Buy Now | Humanigen | $0.01 | — | JP Morgan | Eric Joseph | — | Downgrade | Neutral → Underweight | Get Alert |
| 09/09/2021 | HGEN | Buy Now | Humanigen | $0.01 | 254445.45% | HC Wainwright & Co. | Joseph Pantginis | — | Maintains | Buy | Get Alert |
| 08/13/2021 | HGEN | Buy Now | Humanigen | $0.01 | 218081.82% | Credit Suisse | Tiago Fauth | — | Maintains | Outperform | Get Alert |
| 08/10/2021 | HGEN | Buy Now | Humanigen | $0.01 | 290809.09% | Roth Capital | Tony Butler | — | Maintains | Buy | Get Alert |
| 06/11/2021 | HGEN | Buy Now | Humanigen | $0.01 | 254445.45% | Credit Suisse | Tiago Fauth | — | Initiates | → Outperform | Get Alert |
| 05/07/2021 | HGEN | Buy Now | Humanigen | $0.01 | 272627.27% | Oppenheimer | Kevin DeGeeter | — | Initiates | → Outperform | Get Alert |
| 04/12/2021 | HGEN | Buy Now | Humanigen | $0.01 | 327172.73% | HC Wainwright & Co. | — | — | Reiterates | → Buy | Get Alert |
| 12/23/2020 | HGEN | Buy Now | Humanigen | $0.01 | 318081.82% | National Securities Corporation | — | — | Initiates | → Buy | Get Alert |
| 12/22/2020 | HGEN | Buy Now | Humanigen | $0.01 | 245354.55% | Jefferies | — | — | Initiates | → Buy | Get Alert |
What is the target price for Humanigen (HGEN)?
The latest price target for Humanigen (OTCEM: HGEN) was reported by Credit Suisse on April 3, 2023. The analyst firm set a price target for $0.50 expecting HGEN to rise to within 12 months (a possible 4445.45% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Humanigen (HGEN)?
The latest analyst rating for Humanigen (OTCEM: HGEN) was provided by Credit Suisse, and Humanigen reiterated their underperform rating.
When is the next analyst rating going to be posted or updated for Humanigen (HGEN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humanigen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humanigen was filed on April 3, 2023 so you should expect the next rating to be made available sometime around April 3, 2024.
Is the Analyst Rating Humanigen (HGEN) correct?
While ratings are subjective and will change, the latest Humanigen (HGEN) rating was a reiterated with a price target of $0.00 to $0.50. The current price Humanigen (HGEN) is trading at is $0.01, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.